- Home
- INDP vs AWH Comparison
INDP vs AWH Comparison
Compare INDP & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- AWH
- Stock Information
- Founded
- INDP 2000
- AWH 1993
- Country
- INDP United States
- AWH United States
- Employees
- INDP N/A
- AWH N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- AWH Medical/Dental Instruments
- Sector
- INDP Health Care
- AWH Health Care
- Exchange
- INDP Nasdaq
- AWH Nasdaq
- Market Cap
- INDP 10.2M
- AWH 12.8M
- IPO Year
- INDP N/A
- AWH N/A
- Fundamental
- Price
- INDP $0.94
- AWH $0.77
- Analyst Decision
- INDP Strong Buy
- AWH Buy
- Analyst Count
- INDP 2
- AWH 2
- Target Price
- INDP $8.50
- AWH $4.40
- AVG Volume (30 Days)
- INDP 25.7K
- AWH 81.4K
- Earning Date
- INDP 11-12-2024
- AWH 11-14-2024
- Dividend Yield
- INDP N/A
- AWH N/A
- EPS Growth
- INDP N/A
- AWH N/A
- EPS
- INDP N/A
- AWH N/A
- Revenue
- INDP N/A
- AWH $8,963,000.00
- Revenue This Year
- INDP N/A
- AWH $11.87
- Revenue Next Year
- INDP N/A
- AWH $79.10
- P/E Ratio
- INDP N/A
- AWH N/A
- Revenue Growth
- INDP N/A
- AWH N/A
- 52 Week Low
- INDP $0.84
- AWH $0.67
- 52 Week High
- INDP $3.10
- AWH $5.65
- Technical
- Relative Strength Index (RSI)
- INDP 40.51
- AWH 48.00
- Support Level
- INDP $0.94
- AWH $0.68
- Resistance Level
- INDP $1.01
- AWH $0.85
- Average True Range (ATR)
- INDP 0.06
- AWH 0.08
- MACD
- INDP 0.00
- AWH 0.00
- Stochastic Oscillator
- INDP 28.24
- AWH 42.86
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.